- Short report
- Open Access
Comparative analysis of rabbit hemorrhagic disease virus (RHDV) and new RHDV2 virus antigenicity, using specific virus-like particles
© Bárcena et al. 2015
- Received: 27 May 2015
- Accepted: 12 August 2015
- Published: 24 September 2015
In 2010 a new Lagovirus related to rabbit haemorrhagic disease virus (RHDV) emerged in France and has since rapidly spread throughout domestic and wild rabbit populations of several European countries. The new virus, termed RHDV2, exhibits distinctive genetic, antigenic and pathogenic features. Notably, RHDV2 kills rabbits previously vaccinated with RHDV vaccines. Here we report for the first time the generation and characterization of RHDV2-specific virus-like particles (VLPs). Our results further confirmed the differential antigenic properties exhibited by RHDV and RHDV2, highlighting the need of using RHDV2-specific diagnostic assays to monitor the spread of this new virus.
- Capsid Protein
- VP60 Protein
- Rabbit Haemorrhagic Disease Virus
- Rabbit Haemorrhagic Disease Virus
- Rabbit Population
Rabbit haemorrhagic disease (RHD) is a highly infectious and fatal disease of the European rabbit (Oryctolagus cuniculus), (reviewed in ). The etiological agent, rabbit haemorrhagic disease virus (RHDV), belongs to the Lagovirus genus within the Caliciviridae family. This genus comprises several non-pathogenic rabbit caliciviruses, which are genetically related to but relatively distant from RHDV [2,3], and European brown hare syndrome virus (EBHSV). RHDV is highly contagious and usually fatal in adult rabbits, with a mortality range up to 80-100% . Susceptibility to the disease begins in the 5-6th week of life of rabbits and steadily increases up to the 8-9th week when they become fully susceptible. After it was reported in China in 1984, RHD spread rapidly around the world, being currently enzootic in wild rabbit populations in Europe, Australia and New Zealand. When it emerged, RHD dramatically reduced wild rabbit populations and was responsible for great economic losses in the rabbit industry worldwide . Subsequently, efficient inactivated commercial vaccines against RHDV were introduced in the early 1990s, providing a good coverage, since all circulating strains are classified within a single serotype. These vaccines enabled the control of RHD in rabbitries for the last 20 years. Likewise, ELISA methods developed in Italy for the veterinary diagnosis of RHD in domestic rabbits [4,5], were proven effective tools for monitoring RHDV field epidemiology, particularly in surveys conducted in Australia among wild rabbit populations [6,7].
RHDV is a non-enveloped icosahedral single-stranded positive-sense RNA virus. The virus capsid (~40 nm diameter) comprises 90 dimers of a single capsid subunit, the VP60 protein. RHDV as most caliciviruses cannot be grown in cell culture, a fact that has hampered the study of this group of viruses, as well as the development of control measures. A major breakthrough was the finding that expression of recombinant VP60 protein in insect cells results in the formation of virus-like particles (VLPs) that are morphologically and antigenically identical to infectious RHDV virions . RHDV VLPs have been shown to induce full protection of rabbits against a lethal challenge with RHDV [9,10]. These VLPs have also been used for the development of sensitive and reliable tests for detection of antibodies to RHDV [9,11].
The VP60 protein has three domains , an N-terminal arm (NTA), a shell (S) forming a scaffold which protects the viral RNA, and a flexible protruding domain (P) at the capsid surface, which contains determinants for virus-host receptor interactions and antigenic diversity [12,13]. The P domain can be further divided into P1 and P2 subdomains, with P2 subdomain located at the outermost surface-exposed region of the viral capsid.
In 2010 a new RHDV related virus with a distinctive pathogenic profile was identified in France [14,15] and has since rapidly spread throughout domestic and wild rabbit populations of Italy, Spain, Portugal Germany, United Kingdom and the Azores islands [14,16-21]. Unlike RHDV, the new lagovirus, termed RHDV2 or RHDVb in the literature, kills rabbit kits under 30 days of age, as well as rabbits that had been previously vaccinated against RHDV. Further studies have pointed out other distinctive features of RHDV2: it causes an average mortality of 20% in experimentally infected rabbits , which is consistently less than RHDV, and exhibits a broader host range, since it infects other lagomorphs like different hare species [17,22], causing an RHD-like disease. RHDV2 has specific genetic and antigenic profiles. It has been shown that several monoclonal antibodies (MAbs) against RHDV capsid protein fail to react with cognate RHDV2 virions [14,17].
The situation originated by the emergence of RHDV2 virus has raised concerns regarding the impact of the new disease among domestic and wild rabbit populations . Given the serious epizootic situation created, new inactivated vaccines against RHDV2 have been urgently developed and their use has been provisionally allowed in European Union member states. Recently, the World Organization for Animal Health (OIE) Reference Laboratory for RHD (IZSLER, Brescia, Italy), has developed a serological assay based on the use of specific anti-RHDV2 MAbs, rabbit immune serum and virus capsid antigen obtained from RHDV2-infected rabbit liver extracts .
Here we report for the first time the generation and characterisation of RHDV2-specific VLPs, and their use together with RHDV-specific VLPs, to conduct a comparative serological study involving sera from vaccinated and virus-infected rabbits. Our results further confirmed the differential antigenic properties exhibited by RHDV and RHDV2 virus capsids, highlighting the need for using specific serological assays as tools to monitor the epidemiology of this emergent virus, where virus-specific VLPs could represent a convenient alternative to classical virus antigen.
Reactivity of anti-RHDV MAbs against the capsid proteins of RHDV, RHDV2 and EBHSV in indirect ELISA assays.
Epitope location (aa position within VP60 protein)
(aa 549-579, P1 subdomain)
NPISQVAP (aa 326-333, loop 2 at P2 subdomain)
PGNNAT (aa 305-310, loop 1 at P2 subdomain)
Using the same approach (with a dilution range starting from 1/30), we tested sera from rabbits vaccinated against RHDV (ARVILAP vaccine, Laboratorios Ovejero, Spain) or RHDV2 (NOVARVILAP vaccine, Laboratorios Ovejero, Spain or FILAVAC VHD VARIANT vaccine, Filavie, France) collected 21 days after vaccination (Figure 2B). All animals developed specific antibody responses which were consistently higher for the cognate than for the heterologous antigen. Taken together, the results obtained revealed a markedly different antigenicity between both viral capsids, which is consistent with the observed lack of efficient protection afforded by current commercial RHDV vaccines against RHDV2.
The available information regarding sequence alignment studies of lagovirus full-length capsid proteins indicate RHDV2 is phylogenetically distinct from all previously described members of the genus Lagovirus and forms a new genetic group . Amino acid identity among RHDV2 strains is close to 97%, whereas average identity is 89.2% when compared with RHDV strains [14,17]. When the sequence comparison is restricted to the 7 regions of the P domain that show the highest degree of genetic variation (regions V1 to V7 ), the identity between RHDV2 and RHDV strains drops to 60% . Moreover, the crystallographic resolution of the VP60 protruding P domains of RHDV  and RHDV2 , has enabled the analysis of structural differences between both viruses. Although their overall structures are similar, the P1 subdomain helices are slightly shifted and some P2 subdomain loops are oriented differently. Interestingly, amino acid changes between both viral capsid proteins tend to concentrate on the three extended loop regions located at the outer surface of the P2 subdomain . These results provide insights regarding the marked antigenic differences observed between both viruses, remarkably the lack of efficient protection against RHDV2 afforded by current RHDV inactivated vaccines, which has prompted the urgent development and provisional authorization of RHDV2-specific inactivated vaccines.
Epidemiological surveillance of RHD among domestic and wild rabbit populations is performed using serological assays based on the use of RHDV antigen obtained from infected-rabbit liver extracts and virus specific MAbs [4-6]. Commercial test kits based on RHDV VLPs are currently available and have been used in several studies [16,30]. In Australia, early seroepidemiologic surveys  evidenced the circulation of a non-pathogenic rabbit calicivirus (RCV-A1), which was subsequently identified and characterized . Serological assays enabling discrimination of both viruses, based on the use of virus specific VLPs, have been developed . In Europe, the rapid spread of the newly emergent virus RHDV2, which is apparently replacing classical RHDV strains among rabbit populations [14,18] and is capable of infecting lagomorphs from the Lepus genus [17,22], is a major cause of concern. The availability of virus specific reagents such as RHDV2 VLPs, would greatly ease monitorization of field evolution and circulation of RHDV2, as well as its interaction with RHDV when both viruses co-circulate in rabbit populations.
Here we report for the first time the generation and characterization of RHDV2-specific VLPs. Our results further confirmed the differential antigenic properties exhibited by RHDV and RHDV2 capsid proteins. Using sera from both, vaccinated and infected rabbits, it was shown that antibody responses were consistently higher for the cognate than for the heterologous antigen. Interestingly, the results obtained in the serological analysis of sera collected from an apparently healthy wild rabbit population from Central Spain, suggesting high prevalence of RHDV2, were in agreement with previous reports indicating rapid spread of the novel virus through the Iberian Peninsula [16,23].
The VLPs reported in this study might also be useful for the development of vaccines against RHDV2. Current provisionally authorised vaccines for RHDV2 are prepared from liver extracts of experimentally infected rabbits. Since RHDV2 induces consistently low mortality rates (20-30%) as compared to RHDV (close to 100%), this might represent an important drawback for vaccine production (i.e. lower yields of virus antigen per infected rabbit). Therefore, the development of new recombinant subunit vaccines for RHDV2 based on VLPs might provide greater benefit than the equivalent for RHDV.
In addition, this work enabled the characterization of our MAbs 2E7, 1G5 and 1C9, regarding their differential reactivity with three lagovirus capsid proteins (RHDV, RHDV2 and EBHSV). In summary, the RHDV2 VLPs and the MAbs reported in this study provide tools that might be useful for monitorization of virus circulation, development of control measures, as well as for research in different aspects of the biology of this relevant emergent virus.
We thank Yolanda Gómez for the technical assistance and David Ayensa for his collaboration providing sera samples from rabbits vaccinated with RHDV and RHDV2 vaccines. The authors are grateful to his Grace the Duke of Westminster for his support during the study as well as the staff of “La Garganta” and A. Sonia Olmeda and María Teresa Cutuli from the Veterinary Faculty of UCM for their assistance during sampling. This work was funded by grants AGL2013-48923-C2-1-R to EB and BFU2014-55475 to JRC (Spanish Ministry of Economy and Competitiveness) and P2013/ABI-2906 (PLATESA, Comunidad Autónoma de Madrid) to EB.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Abrantes J, van der Loo W, Le Pendu J, Esteves PJ (2012) Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet Res 43:12PubMed CentralView ArticlePubMedGoogle Scholar
- Strive T, Wright JD, Robinson AJ (2009) Identification and partial characterisation of a new Lagovirus in Australian wild rabbits. Virology 384:97–105View ArticlePubMedGoogle Scholar
- Le Gall-Reculé G, Zwingelstein F, Fages MP, Bertagnoli S, Gelfi J, Aubineau J, Roobrouck A, Botti G, Lavazza A, Marchandeau S (2011) Characterisation of a non-pathogenic and non-protective infectious rabbit lagovirus related to RHDV. Virology 410:395–402View ArticlePubMedGoogle Scholar
- OIE Terrestrial manual. Chapter 2.6.2. Rabbit haemorrhagic disease http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.06.02_RHD.pdf. Accessed 27 July 2015
- Capucci L, Scicluna MT, Lavazza A (1991) Diagnosis of viral haemorrhagic disease of rabbits and the European brown hare syndrome. Rev Sci Tech 10:347–370PubMedGoogle Scholar
- Cooke BD, Robinson AJ, Merchant JC, Nardin A, Capucci L (2000) Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia. Epidemiol Infect 124:563–576PubMed CentralView ArticlePubMedGoogle Scholar
- Robinson AJ, Kirkland PD, Forrester RI, Capucci L, Cooke BD, Philbey AW (2002) Serological evidence for the presence of a calicivirus in Australian wild rabbits, Oryctolagus cuniculus, before the introduction of rabbit haemorrhagic disease virus (RHDV): its potential influence on the specificity of a competitive ELISA for RHDV. Wild Res 29:655–662View ArticleGoogle Scholar
- Barcena J, Verdaguer N, Roca R, Morales M, Angulo I, Risco C, Carrascosa JL, Torres JM, Caston JR (2004) The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid. Virology 322:118–134View ArticlePubMedGoogle Scholar
- Nagesha HS, Wang LF, Hyatt AD, Morrissy CJ, Lenghaus C, Westbury HA (1995) Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus. Arch Virol 140:1095–1108View ArticlePubMedGoogle Scholar
- Crisci E, Barcena J, Montoya M (2012) Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol 148:211–225View ArticlePubMedGoogle Scholar
- Liu J, Kerr PJ, Wright JD, Strive T (2012) Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus. Vet Microbiol 157:345–354View ArticlePubMedGoogle Scholar
- Wang X, Xu F, Liu J, Gao B, Liu Y, Zhai Y, Ma J, Zhang K, Baker TS, Schulten K, Zheng D, Pang H, Sun F (2013) Atomic model of rabbit hemorrhagic disease virus by cryo-electron microscopy and crystallography. PLoS Pathog 9:e1003132PubMed CentralView ArticlePubMedGoogle Scholar
- Capucci L, Frigoli G, Ronshold L, Lavazza A, Brocchi E, Rossi C (1995) Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies. Virus Res 37:221–238View ArticlePubMedGoogle Scholar
- Le Gall-Reculé G, Lavazza A, Marchandeau S, Bertagnoli S, Zwingelstein F, Cavadini P, Martinelli N, Lombardi G, Guérin JL, Lemaitre E, Decors A, Boucher S, Le Normand B, Capucci L (2013) Emergence of a new lagovirus related to Rabbit Haemorrhagic Disease Virus. Vet Res 44:81PubMed CentralView ArticlePubMedGoogle Scholar
- Le Gall-Reculé G, Zwingelstein F, Boucher S, Le Normand B, Plassiart G, Portejoie Y, Decors A, Bertagnoli S, Guérin JL, Marchandeau S (2011) Detection of a new variant of rabbit haemorrhagic disease virus in France. Vet Rec 168:137–138View ArticlePubMedGoogle Scholar
- Dalton KP, Nicieza I, Abrantes J, Esteves PJ, Parra F (2014) Spread of new variant RHDV in domestic rabbits on the Iberian Peninsula. Vet Microbiol 169:67–73View ArticlePubMedGoogle Scholar
- Puggioni G, Cavadini P, Maestrale C, Scivoli R, Botti G, Ligios C, Le Gall-Reculé G, Lavazza A, Capucci L (2013) The new French 2010 Rabbit Hemorrhagic Disease Virus causes an RHD-like disease in the Sardinian Cape hare (Lepus capensis mediterraneus). Vet Res 44:96PubMed CentralView ArticlePubMedGoogle Scholar
- Lopes AM, Correia J, Abrantes J, Melo P, Ramada M, Magalhaes MJ, Alves PC, Esteves PJ (2015) Is the new variant RHDV replacing genogroup 1 in Portuguese wild rabbit populations? Viruses 7:27–36PubMed CentralView ArticleGoogle Scholar
- Dalton KP, Abrantes J, Lopes AM, Nicieza I, Alvarez AL, Esteves PJ, Parra F (2015) Complete genome sequence of two rabbit hemorrhagic disease virus variant b isolates detected on the Iberian Peninsula. Arch Virol 160:877–881View ArticlePubMedGoogle Scholar
- Westcott DG, Frossard JP, Everest D, Dastjerdi A, Duff JP, Steinbach F, Choudhury B (2014) Incursion of RHDV2-like variant in Great Britain. Vet Rec 174:333View ArticlePubMedGoogle Scholar
- Duarte M, Henriques M, Barros SC, Fagulha T, Ramos F, Luis T, Fevereiro M, Benevides S, Flor L, Barros SV, Bernardo S (2015) Detection of RHDV variant 2 in the Azores. Vet Rec 176:130View ArticlePubMedGoogle Scholar
- Camarda A, Pugliese N, Cavadini P, Circella E, Capucci L, Caroli A, Legretto M, Mallia E, Lavazza A (2014) Detection of the new emerging rabbit haemorrhagic disease type 2 virus (RHDV2) in Sicily from rabbit (Oryctolagus cuniculus) and Italian hare (Lepus corsicanus). Res Vet Sci 97:642–645View ArticlePubMedGoogle Scholar
- Delibes-Mateos M, Ferreira C, Carro F, Escudero MA, Gortazar C (2014) Ecosystem effects of variant rabbit hemorrhagic disease virus, Iberian Peninsula. Emerg Infect Dis 20:2166–2168PubMed CentralView ArticlePubMedGoogle Scholar
- Crisci E, Almanza H, Mena I, Cordoba L, Gomez-Casado E, Caston JR, Fraile L, Barcena J, Montoya M (2009) Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant. Virology 387:303–312View ArticlePubMedGoogle Scholar
- Crisci E, Fraile L, Moreno N, Blanco E, Cabezon R, Costa C, Mussa T, Baratelli M, Martinez-Orellana P, Ganges L, Martínez J, Bárcena J, Montoya M (2012) Chimeric calicivirus-like particles elicit specific immune responses in pigs. Vaccine 30:2427–2439View ArticlePubMedGoogle Scholar
- Luque D, Gonzalez JM, Gomez-Blanco J, Marabini R, Chichon J, Mena I, Angulo I, Carrascosa JL, Verdaguer N, Trus BL, Bárcena J, Castón JR (2012) Epitope insertion at the N-terminal molecular switch of the rabbit hemorrhagic disease virus T = 3 capsid protein leads to larger T = 4 capsids. J Virol 86:6470–6480PubMed CentralView ArticlePubMedGoogle Scholar
- Almanza H, Cubillos C, Angulo I, Mateos F, Caston JR, van der Poel WH, Vinje J, Barcena J, Mena I (2008) Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II. J Clin Microbiol 46:3971–3979PubMed CentralView ArticlePubMedGoogle Scholar
- Lopes AM, Capucci L, Gavier-Widen D, Le Gall-Reculé G, Brocchi E, Barbieri I, Quemener A, Le Pendu J, Geoghegan JL, Holmes EC, Esteves PJ, Abrantes J (2014) Molecular evolution and antigenic variation of European brown hare syndrome virus (EBHSV). Virology 468–470:104–112View ArticlePubMedGoogle Scholar
- Leuthold MM, Dalton KP, Hansman GS (2015) Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens. J Virol 89:2378–2387PubMed CentralView ArticlePubMedGoogle Scholar
- Abrantes J, Lopes AM, Dalton KP, Parra F, Esteves PJ (2014) Detection of RHDVa on the Iberian Peninsula: isolation of an RHDVa strain from a Spanish rabbitry. Arch Virol 159:321–326View ArticlePubMedGoogle Scholar